Endocrine regulation strategy monitoring management system based on data analysis

Abstract

The invention discloses an endocrine regulation strategy monitoring management system based on data analysis, and relates to the field of endocrine regulation monitoring, and the system comprises a management center which is in communication connection with an endocrine regulation module, a data collection module, a data processing module, a data analysis module and a strategy evaluation module. The method comprises the following steps: performing endocrine regulation on a patient with abnormal endocrine, collecting body hormone data of the patient from the beginning to the end of the endocrine regulation, and processing the collected body hormone data of the patient to obtain a thyroid hormone content change broken line graph and an epinephrine content change broken line graph; and analyzing the obtained thyroid hormone content change broken line graph and the epinephrine content change broken line graph to obtain a strategy evaluation coefficient, and evaluating the endocrine regulation strategy according to the obtained strategy evaluation coefficient, so that the accuracy of endocrine regulation strategy evaluation is further improved, and accurate reference is provided for hospitals.

Description

Technical Field

[0001] The present invention relates to the field of endocrine regulation monitoring, and in particular to an endocrine regulation strategy monitoring and management system based on data analysis. Background Art

[0002] The endocrine system plays a vital role in the human body, regulating multiple physiological functions including metabolism, immune response, growth and development, and emotions. With the changes in lifestyle, the intensification of environmental pollution, and the aging of the population, the incidence of endocrine system diseases (such as diabetes, thyroid disease, polycystic ovary syndrome, etc.) is on the rise. Effectively monitoring and managing the health of the endocrine system and effectively evaluating endocrine regulation strategies have become important topics in modern medicine.

[0003] How to process the patient's body hormone data, obtain the line graph of thyroid hormone content changes and the line graph of adrenaline content changes, analyze the obtained line graph of thyroid hormone content changes and the line graph of adrenaline content changes, obtain the strategy evaluation coefficient, evaluate the endocrine regulation strategy according to the obtained strategy evaluation coefficient, and further improve the accuracy of the endocrine regulation strategy evaluation are the problems we need to solve. To this end, an endocrine regulation strategy monitoring and management system based on data analysis is now provided. Summary of the invention

[0004] In order to solve the above technical problems, the purpose of the present invention is to provide an endocrine regulation strategy monitoring and management system based on data analysis.

[0005] The object of the present invention can be achieved by the following technical solutions: an endocrine regulation strategy monitoring and management system based on data analysis, comprising a management center, wherein the management center is communicatively connected with an endocrine regulation module, a data acquisition module, a data processing module, a data analysis module and a strategy evaluation module;

[0006] The endocrine regulation module is used to perform endocrine regulation on patients with endocrine abnormalities;

[0007] The data acquisition module is used to collect the patient's body hormone data from the beginning to the end of endocrine regulation;

[0008] The data processing module is used to process the collected body hormone data of the patient to obtain a line graph of changes in thyroid hormone content and a line graph of changes in adrenaline content;

[0009] The data analysis module is used to analyze the obtained thyroid hormone content change line graph and adrenaline content change line graph to obtain a strategy evaluation coefficient;

[0010] The strategy evaluation module is used to evaluate the endocrine regulation strategy according to the obtained strategy evaluation coefficient.

[0011] Furthermore, the process of the endocrine regulation module performing endocrine regulation on patients with endocrine abnormalities includes:

[0012] The endocrine regulation module is provided with an endocrine regulation strategy acquisition module, and the endocrine regulation strategy acquisition module is used to acquire endocrine regulation strategies;

[0013] The endocrine regulation strategy acquisition module is configured to generate a corresponding configuration channel, and the server of the hospital is linked through the generated configuration channel. The endocrine regulation strategy acquisition module obtains the endocrine regulation strategy in the server of the hospital through the corresponding configuration channel;

[0014] Different endocrine regulation strategies are used to regulate endocrine function for corresponding patients.

[0015] Furthermore, the process of the data collection module collecting the patient's body hormone data from the beginning to the end of endocrine regulation includes:

[0016] The patient's body hormone data includes the content of thyroid hormone and adrenaline in the patient's body;

[0017] The data acquisition module is composed of a thyroid hormone acquisition terminal and an adrenaline acquisition terminal. The thyroid hormone acquisition terminal is used to collect the content of thyroid hormone in the patient's body, and the adrenaline acquisition terminal is used to collect the content of adrenaline in the patient's body.

[0018] The thyroid hormone content in the patient's body is obtained through the thyroid hormone collection terminal, and the adrenaline content in the patient's body is obtained through the adrenaline collection terminal.

[0019] Furthermore, the process of the data processing module processing the collected body hormone data of the patient includes:

[0020] Constructing a two-dimensional rectangular coordinate system of the content of thyroid hormone in the patient's body in relation to time, mapping the acquired content of thyroid hormone in the patient's body to the constructed two-dimensional rectangular coordinate system of the content of thyroid hormone in the patient's body in relation to time, generating corresponding thyroid hormone content sample points, and connecting each thyroid hormone content sample point in sequence through a broken line in chronological order to obtain a broken line graph of the patient's thyroid hormone content change;

[0021] A two-dimensional rectangular coordinate system of the adrenaline content in the patient's body with respect to time is constructed, the acquired adrenaline content in the patient's body is mapped to the constructed two-dimensional rectangular coordinate system of the adrenaline content in the patient's body with respect to time, corresponding adrenaline content sample points are generated, and each adrenaline content sample point is sequentially connected by a broken line in chronological order to obtain a line graph of the patient's adrenaline content change.

[0022] Furthermore, the process of the data analysis module analyzing the obtained thyroid hormone content change line graph and adrenaline content change line graph includes:

[0023] The strategy evaluation coefficients include a first strategy evaluation coefficient, a second strategy evaluation coefficient, a third strategy evaluation coefficient and a fourth strategy evaluation coefficient;

[0024] Obtaining a first strategy evaluation coefficient and a second strategy evaluation coefficient according to the obtained thyroid hormone content change line graph;

[0025] The third strategy evaluation coefficient and the fourth strategy evaluation coefficient are obtained according to the obtained adrenaline content change line graph.

[0026] Furthermore, the process of obtaining the first strategy evaluation coefficient and the second strategy evaluation coefficient according to the obtained thyroid hormone content change line graph includes:

[0027] A thyroid hormone content threshold range is set according to actual conditions, and the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is obtained. When the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is greater than the maximum value in the thyroid hormone content threshold range, a straight line is drawn through the thyroid hormone content sample point parallel to the vertical axis, and the tangent value of the angle between the straight line and the line segment between the thyroid hormone content sample point and the next thyroid hormone content sample point is obtained;

[0028] Obtaining the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point, and obtaining a first proximity coefficient according to the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point and the thyroid hormone content threshold range;

[0029] Obtaining a first strategy evaluation coefficient according to the obtained tangent value and the obtained first proximity coefficient;

[0030] When the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is less than the minimum value in the thyroid hormone content threshold range, a straight line parallel to the horizontal axis is drawn through the thyroid hormone content sample point, and the tangent value of the angle between the straight line and the line segment between the thyroid hormone content sample point and the next thyroid hormone content sample point is obtained;

[0031] A second proximity coefficient is obtained, and a second strategy evaluation coefficient is obtained according to the obtained tangent value and the second proximity coefficient.

[0032] Further, the process of obtaining the first proximity coefficient according to the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point and the thyroid hormone content threshold range includes:

[0033] The thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point is subtracted from the maximum value in the thyroid hormone content threshold range, and the subtraction result is performed with an absolute value operation. The thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point is subtracted from the minimum value in the thyroid hormone content threshold range, and the subtraction result is performed with an absolute value operation. The two absolute value operation results are added to obtain a first proximity coefficient.

[0034] Furthermore, the process of the strategy evaluation module evaluating the endocrine regulation strategy according to the obtained strategy evaluation coefficient includes:

[0035] According to actual conditions, a first strategy evaluation coefficient threshold, a second strategy evaluation coefficient threshold, a third strategy evaluation coefficient threshold and a fourth strategy evaluation coefficient threshold are set;

[0036] When the first strategy evaluation coefficient is less than the first strategy evaluation coefficient threshold or the second strategy evaluation coefficient is greater than the second strategy evaluation coefficient threshold, the third strategy evaluation coefficient is less than the third strategy evaluation coefficient threshold or the fourth strategy evaluation coefficient is greater than the fourth strategy evaluation coefficient threshold, the endocrine regulation strategy adopted by the patient is qualified;

[0037] For the remaining cases, the endocrine regulation strategy adopted by the patients was substandard.

[0038] Compared with the prior art, the beneficial effects of the present invention are: performing endocrine regulation on patients with endocrine abnormalities, collecting the patient's body hormone data from the beginning to the end of the endocrine regulation, processing the collected patient's body hormone data, obtaining a line graph of thyroid hormone content changes and a line graph of adrenaline content changes, analyzing the obtained line graph of thyroid hormone content changes and the line graph of adrenaline content changes to obtain a strategy evaluation coefficient, and evaluating the endocrine regulation strategy based on the obtained strategy evaluation coefficient, thereby further improving the accuracy of the endocrine regulation strategy evaluation and providing an accurate reference for hospitals. BRIEF DESCRIPTION OF THE DRAWINGS

[0039] Figure 1 It is a schematic diagram of the present invention. DETAILED DESCRIPTION

[0040] like Figure 1 As shown, an endocrine regulation strategy monitoring and management system based on data analysis includes a management center, and the management center is communicatively connected with an endocrine regulation module, a data acquisition module, a data processing module, a data analysis module and a strategy evaluation module;

[0041] The endocrine regulation module is used to perform endocrine regulation on patients with endocrine abnormalities;

[0042] It should be further explained that, in the specific implementation process, the process of the endocrine regulation module performing endocrine regulation on patients with endocrine abnormalities includes:

[0043] The endocrine regulation module is provided with an endocrine regulation strategy acquisition module, and the endocrine regulation strategy acquisition module is used to acquire endocrine regulation strategies;

[0044] The endocrine regulation strategy acquisition module is configured to generate a corresponding configuration channel, and the server of the hospital is linked through the generated configuration channel. The endocrine regulation strategy acquisition module obtains the endocrine regulation strategy in the server of the hospital through the corresponding configuration channel;

[0045] Different endocrine regulation strategies are used to regulate the endocrine of the corresponding patients, and the patients are labeled as i, i=1, 2, 3, ..., n, where n is a positive integer.

[0046] The data acquisition module is used to collect the patient's body hormone data from the beginning to the end of endocrine regulation;

[0047] It should be further explained that, in the specific implementation process, the process in which the data collection module collects the patient's body hormone data from the beginning to the end of endocrine regulation includes:

[0048] The patient's body hormone data includes the content of thyroid hormone, adrenaline, luteinizing hormone, progesterone, follicle-stimulating hormone, etc. in the patient's body;

[0049] The data acquisition module is composed of a thyroid hormone acquisition terminal and an adrenaline acquisition terminal. The thyroid hormone acquisition terminal is used to collect the content of thyroid hormone in the patient's body, and the adrenaline acquisition terminal is used to collect the content of adrenaline in the patient's body.

[0050] The thyroid hormone content in the patient's body is obtained through the thyroid hormone collection terminal, and the adrenaline content in the patient's body is obtained through the adrenaline collection terminal.

[0051] The data processing module is used to process the collected body hormone data of the patient to obtain a line graph of changes in thyroid hormone content and a line graph of changes in adrenaline content;

[0052] It should be further explained that, in the specific implementation process, the data processing module processes the collected body hormone data of the patient to obtain a line graph of thyroid hormone content changes and a line graph of adrenaline content changes, including:

[0053] Constructing a two-dimensional rectangular coordinate system of the thyroid hormone content in the patient's body in terms of time, mapping the acquired thyroid hormone content in the patient's body to the constructed two-dimensional rectangular coordinate system of the thyroid hormone content in the patient's body in terms of time, generating corresponding thyroid hormone content sample points, labeling the generated thyroid hormone content sample points as j, where j=1, 2, 3, ..., m, where m is a positive integer, and connecting each thyroid hormone content sample point in chronological order through a broken line in sequence to obtain a broken line graph of the patient's thyroid hormone content change;

[0054] A two-dimensional rectangular coordinate system of the adrenaline content in the patient's body with respect to time is constructed, the acquired adrenaline content in the patient's body is mapped to the constructed two-dimensional rectangular coordinate system of the adrenaline content in the patient's body with respect to time, corresponding adrenaline content sample points are generated, the generated adrenaline content sample points are labeled as i, and each adrenaline content sample point is sequentially connected by a broken line in chronological order to obtain a line graph of the patient's adrenaline content change.

[0055] The data analysis module is used to analyze the obtained thyroid hormone content change line graph and adrenaline content change line graph to obtain a strategy evaluation coefficient;

[0056] It should be further explained that, in the specific implementation process, the data analysis module analyzes the obtained thyroid hormone content change line graph and adrenaline content change line graph, and the process of obtaining the strategy evaluation coefficient includes:

[0057] The strategy evaluation coefficients include a first strategy evaluation coefficient, a second strategy evaluation coefficient, a third strategy evaluation coefficient and a fourth strategy evaluation coefficient;

[0058] Obtaining a first strategy evaluation coefficient and a second strategy evaluation coefficient according to the obtained thyroid hormone content change line graph;

[0059] It should be further explained that, in the specific implementation process, the process of obtaining the first strategy evaluation coefficient and the second strategy evaluation coefficient according to the obtained thyroid hormone content change line graph includes:

[0060] The thyroid hormone content threshold range is set according to the actual situation, and the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is obtained. When the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is greater than the maximum value in the thyroid hormone content threshold range, a straight line parallel to the vertical axis is drawn through the thyroid hormone content sample point to obtain the tangent value of the angle between the straight line and the line segment between the thyroid hormone content sample point and the next thyroid hormone content sample point, and the obtained tangent value is recorded as Z ij , j≠m;

[0061] Obtain the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point, subtract the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point from the maximum value in the thyroid hormone content threshold range, perform an absolute value operation on the subtraction result, subtract the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point from the minimum value in the thyroid hormone content threshold range, perform an absolute value operation on the subtraction result, add the results of the two absolute value operations, obtain a first proximity coefficient, and record the obtained first proximity coefficient as L i ;

[0062] According to the obtained tangent value and the obtained first proximity coefficient, the first strategy evaluation coefficient is obtained, and the obtained first strategy evaluation coefficient is recorded as ZL i ;

[0063] in, ; kp_1 is the adjustment coefficient of the tangent value, kp_2 is the adjustment coefficient of the first adjacent coefficient;

[0064] When the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is less than the minimum value in the thyroid hormone content threshold range, a straight line parallel to the horizontal axis is drawn through the thyroid hormone content sample point to obtain the tangent value of the angle between the straight line and the line segment between the thyroid hormone content sample point and the next thyroid hormone content sample point, and the obtained tangent value is recorded as Q ij , j≠m;

[0065] Obtain the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point, subtract the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point from the maximum value in the thyroid hormone content threshold range, perform an absolute value operation on the subtraction result, subtract the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point from the minimum value in the thyroid hormone content threshold range, perform an absolute value operation on the subtraction result, add the results of the two absolute value operations, obtain a second neighbor coefficient, and record the obtained second neighbor coefficient as Ki ;

[0066] According to the obtained tangent value and the obtained second proximity coefficient, the second strategy evaluation coefficient is obtained, and the obtained second strategy evaluation coefficient is recorded as QK i ;

[0067] in, ; kp_3 is the adjustment coefficient of the tangent value, kp_4 is the adjustment coefficient of the second adjacent coefficient;

[0068] Obtaining a third strategy evaluation coefficient and a fourth strategy evaluation coefficient according to the obtained adrenaline content change line graph;

[0069] It should be further explained that, in the specific implementation process, the process of obtaining the third strategy evaluation coefficient and the fourth strategy evaluation coefficient according to the obtained adrenaline content change line graph includes:

[0070] The adrenaline content threshold range is set according to the actual situation, and the adrenaline content in the patient's body corresponding to the first adrenaline content sample point is obtained. When the adrenaline content in the patient's body corresponding to the first adrenaline content sample point is greater than the maximum value in the adrenaline content threshold range, a straight line parallel to the longitudinal axis is drawn through the adrenaline content sample point, and the tangent value of the angle between the straight line and the line segment between the adrenaline content sample point and the next adrenaline content sample point is obtained. The obtained tangent value is recorded as A ij , j≠m;

[0071] Obtain the adrenaline content in the patient's body corresponding to the last adrenaline content sample point, subtract the adrenaline content in the patient's body corresponding to the last adrenaline content sample point from the maximum value in the adrenaline content threshold range, perform an absolute value operation on the subtraction result, subtract the adrenaline content in the patient's body corresponding to the last adrenaline content sample point from the minimum value in the adrenaline content threshold range, perform an absolute value operation on the subtraction result, add the two absolute value operation results to obtain a third proximity coefficient, and record the obtained third proximity coefficient as B i ;

[0072] According to the obtained tangent value and the obtained third proximity coefficient, the third strategy evaluation coefficient is obtained, and the obtained third strategy evaluation coefficient is recorded as AB i ;

[0073] in, ; up_1 is the adjustment coefficient of the tangent value, up_2 is the adjustment coefficient of the third adjacent coefficient;

[0074] When the adrenaline content in the patient's body corresponding to the first adrenaline content sample point is less than the minimum value in the adrenaline content threshold range, a straight line parallel to the horizontal axis is drawn through the adrenaline content sample point, and the tangent value of the angle between the straight line and the line segment between the adrenaline content sample point and the next adrenaline content sample point is obtained, and the obtained tangent value is recorded as C ij , j≠m;

[0075] Obtain the adrenaline content in the patient's body corresponding to the last adrenaline content sample point, subtract the adrenaline content in the patient's body corresponding to the last adrenaline content sample point from the maximum value in the adrenaline content threshold range, perform an absolute value operation on the subtraction result, subtract the adrenaline content in the patient's body corresponding to the last adrenaline content sample point from the minimum value in the adrenaline content threshold range, perform an absolute value operation on the subtraction result, add the two absolute value operation results to obtain a fourth proximity coefficient, and record the obtained fourth proximity coefficient as D i ;

[0076] According to the obtained tangent value and the obtained fourth proximity coefficient, the fourth strategy evaluation coefficient is obtained, and the obtained fourth strategy evaluation coefficient is recorded as CD i ;

[0077] in, ; up_3 is the adjustment coefficient of the tangent value, and up_4 is the adjustment coefficient of the fourth adjacent coefficient.

[0078] The strategy evaluation module is used to evaluate the endocrine regulation strategy according to the obtained strategy evaluation coefficient;

[0079] It should be further explained that, in the specific implementation process, the process in which the strategy evaluation module evaluates the endocrine regulation strategy according to the obtained strategy evaluation coefficient includes:

[0080] According to actual conditions, a first strategy evaluation coefficient threshold, a second strategy evaluation coefficient threshold, a third strategy evaluation coefficient threshold and a fourth strategy evaluation coefficient threshold are set;

[0081] When the first strategy evaluation coefficient is less than the first strategy evaluation coefficient threshold or the second strategy evaluation coefficient is greater than the second strategy evaluation coefficient threshold, the third strategy evaluation coefficient is less than the third strategy evaluation coefficient threshold or the fourth strategy evaluation coefficient is greater than the fourth strategy evaluation coefficient threshold, the endocrine regulation strategy adopted by the patient is qualified;

[0082] For the remaining cases, the endocrine regulation strategy adopted by the patients was substandard.

[0083] The above embodiments are only used to illustrate the technical method of the present invention rather than to limit it. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical method of the present invention may be modified or replaced by equivalents without departing from the spirit and scope of the technical method of the present invention.

Claims

1. An endocrine regulation strategy monitoring and management system based on data analysis, comprising a management center, characterized in that: The management center is communicatively connected to an endocrine regulation module, a data acquisition module, a data processing module, a data analysis module, and a strategy evaluation module; The endocrine regulation module is used to perform endocrine regulation on patients with endocrine abnormalities; The data acquisition module is used to collect the patient's body hormone data from the beginning to the end of endocrine regulation; The data processing module is used to process the collected body hormone data of the patient to obtain a line graph of changes in thyroid hormone content and a line graph of changes in adrenaline content; The data analysis module is used to analyze the obtained thyroid hormone content change line graph and adrenaline content change line graph to obtain a strategy evaluation coefficient; The strategy evaluation module is used to evaluate the endocrine regulation strategy according to the obtained strategy evaluation coefficient.

2. According to claim 1, the endocrine regulation strategy monitoring and management system based on data analysis is characterized in that: The process of the endocrine regulation module performing endocrine regulation on patients with endocrine abnormalities includes: The endocrine regulation module is provided with an endocrine regulation strategy acquisition module, and the endocrine regulation strategy acquisition module is used to acquire endocrine regulation strategies; The endocrine regulation strategy acquisition module is configured to generate a corresponding configuration channel, and the server of the hospital is linked through the generated configuration channel. The endocrine regulation strategy acquisition module obtains the endocrine regulation strategy in the server of the hospital through the corresponding configuration channel; Different endocrine regulation strategies are used to regulate endocrine function for corresponding patients.

3. The endocrine regulation strategy monitoring and management system based on data analysis according to claim 2 is characterized in that: The process of the data acquisition module acquiring the patient's body hormone data from the beginning to the end of endocrine regulation includes: The patient's body hormone data includes the content of thyroid hormone and adrenaline in the patient's body; The data acquisition module is composed of a thyroid hormone acquisition terminal and an adrenaline acquisition terminal. The thyroid hormone acquisition terminal is used to collect the content of thyroid hormone in the patient's body, and the adrenaline acquisition terminal is used to collect the content of adrenaline in the patient's body. The thyroid hormone content in the patient's body is obtained through the thyroid hormone collection terminal, and the adrenaline content in the patient's body is obtained through the adrenaline collection terminal.

4. The endocrine regulation strategy monitoring and management system based on data analysis according to claim 3 is characterized in that: The process of the data processing module processing the collected patient's body hormone data includes: Constructing a two-dimensional rectangular coordinate system of the content of thyroid hormone in the patient's body in relation to time, mapping the acquired content of thyroid hormone in the patient's body to the constructed two-dimensional rectangular coordinate system of the content of thyroid hormone in the patient's body in relation to time, generating corresponding thyroid hormone content sample points, and connecting each thyroid hormone content sample point in sequence through a broken line in chronological order to obtain a broken line graph of the patient's thyroid hormone content change; A two-dimensional rectangular coordinate system of the adrenaline content in the patient's body with respect to time is constructed, the acquired adrenaline content in the patient's body is mapped to the constructed two-dimensional rectangular coordinate system of the adrenaline content in the patient's body with respect to time, corresponding adrenaline content sample points are generated, and each adrenaline content sample point is sequentially connected by a broken line in chronological order to obtain a line graph of the patient's adrenaline content change.

5. The endocrine regulation strategy monitoring and management system based on data analysis according to claim 4, characterized in that: The process of the data analysis module analyzing the obtained thyroid hormone content change line graph and adrenaline content change line graph includes: The strategy evaluation coefficients include a first strategy evaluation coefficient, a second strategy evaluation coefficient, a third strategy evaluation coefficient and a fourth strategy evaluation coefficient; Obtaining a first strategy evaluation coefficient and a second strategy evaluation coefficient according to the obtained thyroid hormone content change line graph; The third strategy evaluation coefficient and the fourth strategy evaluation coefficient are obtained according to the obtained adrenaline content change line graph.

6. The endocrine regulation strategy monitoring and management system based on data analysis according to claim 5, characterized in that: The process of obtaining the first strategy evaluation coefficient and the second strategy evaluation coefficient according to the obtained thyroid hormone content change line graph includes: A thyroid hormone content threshold range is set according to actual conditions, and the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is obtained. When the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is greater than the maximum value in the thyroid hormone content threshold range, a straight line is drawn through the thyroid hormone content sample point parallel to the vertical axis, and the tangent value of the angle between the straight line and the line segment between the thyroid hormone content sample point and the next thyroid hormone content sample point is obtained; Obtaining the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point, and obtaining a first proximity coefficient according to the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point and the thyroid hormone content threshold range; Obtaining a first strategy evaluation coefficient according to the obtained tangent value and the obtained first proximity coefficient; When the thyroid hormone content in the patient's body corresponding to the first thyroid hormone content sample point is less than the minimum value in the thyroid hormone content threshold range, a straight line parallel to the horizontal axis is drawn through the thyroid hormone content sample point, and the tangent value of the angle between the straight line and the line segment between the thyroid hormone content sample point and the next thyroid hormone content sample point is obtained; A second proximity coefficient is obtained, and a second strategy evaluation coefficient is obtained according to the obtained tangent value and the second proximity coefficient.

7. The endocrine regulation strategy monitoring and management system based on data analysis according to claim 6, characterized in that: The process of obtaining the first proximity coefficient according to the thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point and the thyroid hormone content threshold range includes: The thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point is subtracted from the maximum value in the thyroid hormone content threshold range, and the subtraction result is performed with an absolute value operation. The thyroid hormone content in the patient's body corresponding to the last thyroid hormone content sample point is subtracted from the minimum value in the thyroid hormone content threshold range, and the subtraction result is performed with an absolute value operation. The two absolute value operation results are added to obtain a first proximity coefficient.

8. The endocrine regulation strategy monitoring and management system based on data analysis according to claim 7, characterized in that: The process of the strategy evaluation module evaluating the endocrine regulation strategy according to the obtained strategy evaluation coefficient includes: According to actual conditions, a first strategy evaluation coefficient threshold, a second strategy evaluation coefficient threshold, a third strategy evaluation coefficient threshold and a fourth strategy evaluation coefficient threshold are set; When the first strategy evaluation coefficient is less than the first strategy evaluation coefficient threshold or the second strategy evaluation coefficient is greater than the second strategy evaluation coefficient threshold, the third strategy evaluation coefficient is less than the third strategy evaluation coefficient threshold or the fourth strategy evaluation coefficient is greater than the fourth strategy evaluation coefficient threshold, the endocrine regulation strategy adopted by the patient is qualified; For the remaining cases, the endocrine regulation strategy adopted by the patients was substandard.

Images